Atossa Genetics Net Income vs. Total Debt
| ATOS Stock | USD 0.78 0.01 1.27% |
Net Loss | First Reported 2009-09-30 | Previous Quarter -6.7 M | Current Value -8.4 M | Quarterly Volatility 2.4 M |
For Atossa Genetics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Atossa Genetics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Atossa Genetics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Atossa Genetics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Atossa Genetics over time as well as its relative position and ranking within its peers.
Check out Trending Equities. Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atossa Genetics. If investors know Atossa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atossa Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Atossa Genetics is measured differently than its book value, which is the value of Atossa that is recorded on the company's balance sheet. Investors also form their own opinion of Atossa Genetics' value that differs from its market value or its book value, called intrinsic value, which is Atossa Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atossa Genetics' market value can be influenced by many factors that don't directly affect Atossa Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atossa Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Atossa Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atossa Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Atossa Genetics Total Debt vs. Net Income Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Atossa Genetics's current stock value. Our valuation model uses many indicators to compare Atossa Genetics value to that of its competitors to determine the firm's financial worth. Atossa Genetics is rated second in net income category among its peers. It is rated below average in total debt category among its peers . At this time, Atossa Genetics' Net Loss is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Atossa Genetics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Atossa Total Debt vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Atossa Genetics |
| = | (25.5 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Atossa Genetics |
| = | 4.97 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Atossa Total Debt vs Competition
Atossa Genetics is rated below average in total debt category among its peers. Total debt of Health Care industry is presently estimated at about 222.11 Million. Atossa Genetics holds roughly 4.97 Million in total debt claiming about 2.24% of equities under Health Care industry.
Atossa Genetics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Atossa Genetics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Atossa Genetics will eventually generate negative long term returns. The profitability progress is the general direction of Atossa Genetics' change in net profit over the period of time. It can combine multiple indicators of Atossa Genetics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -27.6 M | -26.2 M | |
| Income Before Tax | -25.5 M | -24.2 M | |
| Net Loss | -25.5 M | -24.2 M | |
| Total Other Income Expense Net | 2.1 M | 2.2 M | |
| Income Tax Expense | -840.6 K | -798.6 K | |
| Net Loss | -25.5 M | -24.2 M | |
| Non Operating Income Net Other | 657.9 K | 690.8 K | |
| Net Loss | -24.3 M | -25.5 M | |
| Interest Income | 4 M | 4.3 M | |
| Net Interest Income | 4 M | 4.3 M | |
| Change To Netincome | 7.8 M | 8.2 M | |
| Net Loss | (0.20) | (0.21) | |
| Income Quality | 0.82 | 0.79 | |
| Net Income Per E B T | 1.11 | 0.90 |
Atossa Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Atossa Genetics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Atossa Genetics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Atossa Genetics' important profitability drivers and their relationship over time.
Use Atossa Genetics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atossa Genetics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atossa Genetics will appreciate offsetting losses from the drop in the long position's value.Atossa Genetics Pair Trading
Atossa Genetics Pair Trading Analysis
The ability to find closely correlated positions to Atossa Genetics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atossa Genetics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atossa Genetics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atossa Genetics to buy it.
The correlation of Atossa Genetics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atossa Genetics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atossa Genetics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atossa Genetics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Atossa Genetics position
In addition to having Atossa Genetics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Obamacare Repeal Thematic Idea Now
Obamacare Repeal
Healthcare and drug manufacturing companies that will most likely be affected by the final stages of Obamacare repeal. The Obamacare Repeal theme has 56 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Obamacare Repeal Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Atossa Stock Analysis
When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.